FDA draft guidance on computerised systems used in clinical trials

Area of Science:

• Clinical research informatics
• Regulatory science
• Information technology in healthcare

Background:

• Effective management of clinical study computer systems is crucial for data integrity and regulatory compliance.
• Understanding the application of US regulations on electronic records and signatures is essential for studies supporting regulatory submissions.

Purpose of the Study:

• To discuss the control of computer systems used in clinical studies.
• To clarify the applicability of US electronic records and signatures regulations for regulatory submissions.
• To present and analyze a draft guidance document addressing these issues.

Main Methods:

• Review of existing regulations concerning electronic records and signatures in the US.
• Analysis of best practices for controlling computer systems in clinical trial management.
• Examination of a draft guidance document relevant to these topics.

Main Results:

• Identification of key control considerations for clinical study computer systems.
• Clarification of the circumstances under which US electronic records and signatures regulations apply.
• Insights into the recommendations and implications of the draft guidance document.

Conclusions:

• Proper control of clinical study computer systems is vital for regulatory compliance.
• Awareness and adherence to US electronic records and signatures regulations are mandatory for relevant submissions.
• The draft guidance document offers valuable direction for managing these systems and regulatory requirements.